UMMS Affiliation

Commonwealth Medicine, Clinical Pharmacy Services

Publication Date

2018-12-13

Document Type

Blog Post

Disciplines

Health Economics | Health Law and Policy | Health Policy | Health Services Administration | Health Services Research | Insurance | Pharmacoeconomics and Pharmaceutical Economics

Abstract

The Trump Administration Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs calls for incentives to lower drug list prices, including removing rebates. Our clinical consultant Stephanie Tran continues our pharmacy blog series with an assessment of this potential change & its impacts.

Keywords

rebates, drug prices, Department of Health and Human Services, Food and Drug Administration, price increases, generic competition

Rights and Permissions

© 2018 University of Massachusetts Medical School

DOI of Published Version

10.13028/cjft-w740

Journal/Book/Conference Title

Commonwealth Medicine Blog

Comments

Blog post to Commonwealth Medicine's website - view blog post online

Share

COinS